A detailed history of Charles Schwab Investment Management Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 657,554 shares of ILMN stock, worth $94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
657,554
Previous 644,823 1.97%
Holding current value
$94 Million
Previous $67.3 Million 27.4%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$105.28 - $135.9 $1.34 Million - $1.73 Million
12,731 Added 1.97%
657,554 $85.7 Million
Q2 2024

Aug 12, 2024

SELL
$101.05 - $133.57 $31.3 Million - $41.4 Million
-309,599 Reduced 32.44%
644,823 $67.3 Million
Q1 2024

May 08, 2024

BUY
$127.73 - $147.2 $3.73 Million - $4.3 Million
29,224 Added 3.16%
954,422 $131 Million
Q4 2023

Feb 06, 2024

BUY
$92.79 - $142.53 $3.83 Million - $5.89 Million
41,298 Added 4.67%
925,198 $129 Million
Q3 2023

Nov 08, 2023

BUY
$128.91 - $192.44 $898,502 - $1.34 Million
6,970 Added 0.79%
883,900 $121 Million
Q2 2023

Aug 09, 2023

BUY
$183.43 - $232.67 $5.32 Million - $6.75 Million
28,996 Added 3.42%
876,930 $164 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $2.74 Million - $3.28 Million
14,125 Added 1.69%
847,934 $197 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $4.91 Million - $6.37 Million
26,232 Added 3.25%
833,809 $169 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $3.42 Million - $4.39 Million
19,306 Added 2.45%
807,577 $154 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $1.65 Million - $3.35 Million
9,113 Added 1.17%
788,271 $145 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $3.25 Million - $4.54 Million
10,708 Added 1.39%
779,158 $272 Million
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $20.9 Million - $25.4 Million
60,166 Added 8.49%
768,450 $292 Million
Q3 2021

Nov 16, 2021

BUY
$405.61 - $524.84 $12.9 Million - $16.7 Million
31,826 Added 4.7%
708,284 $287 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $5.25 Million - $6.79 Million
14,092 Added 2.13%
676,458 $320 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $21.9 Million - $30.7 Million
-60,755 Reduced 8.4%
662,366 $254 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $5.05 Million - $6.39 Million
17,238 Added 2.44%
723,121 $268 Million
Q3 2020

Nov 13, 2020

BUY
$268.51 - $400.74 $13 Million - $19.5 Million
48,584 Added 7.39%
705,883 $218 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $6.39 Million - $9.29 Million
24,908 Added 3.94%
657,299 $243 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $1.75 Million - $2.8 Million
8,346 Added 1.34%
632,391 $173 Million
Q4 2019

Feb 07, 2020

BUY
$288.29 - $335.49 $2.41 Million - $2.81 Million
8,368 Added 1.36%
624,045 $207 Million
Q3 2019

Nov 08, 2019

BUY
$266.84 - $378.23 $5.04 Million - $7.14 Million
18,883 Added 3.16%
615,677 $187 Million
Q2 2019

Aug 09, 2019

SELL
$300.59 - $368.15 $2.52 Million - $3.08 Million
-8,379 Reduced 1.38%
596,794 $220 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $2.48 Million - $2.92 Million
-9,102 Reduced 1.48%
605,173 $188 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $3.42 Million - $4.6 Million
12,547 Added 2.09%
614,275 $184 Million
Q3 2018

Nov 13, 2018

SELL
$279.04 - $367.06 $805,588 - $1.06 Million
-2,887 Reduced 0.48%
601,728 $221 Million
Q2 2018

Aug 08, 2018

BUY
$228.17 - $292.07 $7.3 Million - $9.34 Million
31,985 Added 5.59%
604,615 $169 Million
Q1 2018

May 07, 2018

BUY
$209.54 - $253.91 $6.61 Million - $8.02 Million
31,567 Added 5.83%
572,630 $135 Million
Q4 2017

Jan 17, 2018

BUY
$202.23 - $230.03 $6.61 Million - $7.52 Million
32,695 Added 6.43%
541,063 $118 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $87.6 Million - $109 Million
508,368
508,368 $101 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.